Therapy News and Research

RSS

Core Biogenesis and Nucleus Biologics announce strategic collaboration for manufacturing and distribution of cost effective and sustainable recombinant proteins

In a joint effort to provide lower cost and more defined reagents and media to the cell and gene therapy market, Nucleus Biologics, The Cell Performance Company™, a leading provider of custom cell culture media solutions for the cell and gene therapy industry, has signed a manufacturing, distribution, and collaboration agreement with Core Biogenesis, an innovator in the field of recombinant human proteins expressed in plants.

From Nucleus Biologics 24 Jan 2024

Bladder and gut fermentation syndromes: Uncommon disorders with significant implications

Study reviews bladder fermentation syndrome (BFS) and gut fermentation syndrome (GFS), highlighting their etiology, diagnosis, and treatment, and emphasizing the importance of recognizing these conditions to avoid misinterpretation in abstinence monitoring.

23 Jan 2024

New workflow identifies shared cancer targets, advancing immunotherapy

Researchers developed the Splicing Neo Antigen Finder (SNAF) workflow, integrating deep learning to identify shared immunogenic neoantigens in cancers, offering new targets for cancer immunotherapy, particularly in melanoma and ovarian cancer.

23 Jan 2024

Combination drug therapy beats solo treatment for aggressive prostate cancer relapse

Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug, a multi-institution, Phase 3 clinical trial led by UC San Francisco researchers has found.

23 Jan 2024

Is a gluten-free diet always the healthier choice for women?

Study evaluates the impact of gluten-free diets on women's health, revealing benefits for specific gluten-related disorders but cautioning against unnecessary dietary restrictions.

23 Jan 2024

Cleveland Clinic and IBM researchers reveal strategy for identifying new immunotherapy targets through AI

Researchers from Cleveland Clinic and IBM have published a strategy for identifying new targets for immunotherapy through artificial intelligence (AI).

23 Jan 2024

AI model identifies sepsis patients before symptoms appear

Each year, at least 1.7 million adults in the United States develop sepsis, and approximately 350,000 will die from the serious blood infection that can trigger a life-threatening chain reaction throughout the entire body.

23 Jan 2024

Long-term prostate cancer treatment study informs decisions for diverse groups

A 10-year follow up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision making in terms of treatments and side effects for a diverse population.

23 Jan 2024

Study provides valuable insights into the evolutionary dynamics of hepatitis E virus

A combination therapy with multiple drugs is more effective than just one active compound. To begin with, at least.

23 Jan 2024

New study reveals effective strategies against drug resistance in hospital-acquired pneumonia treatment

A novel rabbit infection model to investigate meropenem's resistance development.

23 Jan 2024

Body mass index found to mediate causal associations between Helicobacter pylori infections and coronary artery disease risk

Coronary heart disease (CHD) and H. Pylori.

23 Jan 2024

Study identifies link between childhood family environment and cardiovascular health later in life

Throughout adulthood, adverse family experiences in childhood including abuse may increase the odds of poor cardiovascular health, while stable, nurturing caregiver relationships during childhood may increase the chances of optimal heart health throughout adulthood, according to new research published today in Circulation: Cardiovascular Quality and Outcomes, a peer-reviewed American Heart Association journal.

23 Jan 2024

Study identifies genetic variants that influence response to preterm birth treatment

A UC San Francisco-led study has for the first time identified genetic variants that predict whether patients will respond to treatment for preterm birth, a condition that affects one in 10 infants born in the United States.

22 Jan 2024

New study unlocks secrets to preventing birth defects

Cleft lip and palate are the most common craniofacial birth defects in humans, affecting more than 175,000 newborns around the world each year.

22 Jan 2024

Revolutionary bio-sponge halts bleeding instantly

More than 11 million people in the United States take anticoagulation or antiplatelet medications, such as heparin or aspirin, to treat serious conditions like heart attack and stroke.

22 Jan 2024

Rutgers researchers devise strategy to boost prostate cancer treatment efficacy

Rutgers researchers can predict which patients will benefit from a popular prostate cancer drug – and have devised a strategy that may make the treatment work longer.

22 Jan 2024

Study evaluates factors associated with selection of active surveillance for low-risk prostate cancer

Because low-risk prostate cancer is unlikely to spread or impact survival, experts and guidelines recommend active surveillance, which involves regular monitoring and thus avoid or delay treatment like surgery or radiation therapy and their life-changing complications.

22 Jan 2024

Therapy News and Research

Core Biogenesis and Nucleus Biologics announce strategic collaboration for manufacturing and distribution of cost effective and sustainable recombinant proteins

Bladder and gut fermentation syndromes: Uncommon disorders with significant implications

New workflow identifies shared cancer targets, advancing immunotherapy

Combination drug therapy beats solo treatment for aggressive prostate cancer relapse

Is a gluten-free diet always the healthier choice for women?

Cleveland Clinic and IBM researchers reveal strategy for identifying new immunotherapy targets through AI

AI model identifies sepsis patients before symptoms appear

Long-term prostate cancer treatment study informs decisions for diverse groups

Study provides valuable insights into the evolutionary dynamics of hepatitis E virus

New study reveals effective strategies against drug resistance in hospital-acquired pneumonia treatment

Body mass index found to mediate causal associations between Helicobacter pylori infections and coronary artery disease risk

Study identifies link between childhood family environment and cardiovascular health later in life

Study identifies genetic variants that influence response to preterm birth treatment

New study unlocks secrets to preventing birth defects

Revolutionary bio-sponge halts bleeding instantly

Rutgers researchers devise strategy to boost prostate cancer treatment efficacy

Study evaluates factors associated with selection of active surveillance for low-risk prostate cancer

Receptor protein found to be a key player in prostate cancer cells' drug resistance

UMass Amherst researcher aims to tackle bone damage in metastatic cancer

Non-destructive cancer grade probing system evaluates malignancy grade of model glioma cells

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News